Showing results (581-590 of 1,177) with videos related to
Sort By:
Pageof 118
Applied Health Economics and Health Policy|October 12, 2021
Economic Consequences of Anti-HCV Treatment of Patients Diagnosed Through Screening in Italy: A Prospective Modelling AnalysisAndrea Marcellusi, Claudia Simonelli, Francesco S Mennini, et al.Applied Health Economics and Health Policy|June 29, 2010
Audit of Diabetes-Dependent Quality of Life (ADDQoL) [Chinese Version for Singapore] questionnaire: reliability and validity among Singaporeans with type 2 diabetes mellitusSwee Sung Soon, Su Yen Goh, Yong Mong Bee, et al.Applied Health Economics and Health Policy|June 29, 2010
Costs and consequences of clopidogrel versus aspirin for secondary prevention of ischaemic events in (high-risk) atherosclerotic patients in Sweden: a lifetime model based on the CAPRIE trial and high-risk CAPRIE subpopulationsJ Floris S Logman, Bart M S Heeg, Johan Herlitz, et al.Applied Health Economics and Health Policy|September 1, 2010
Cost of illness and drivers of cost in atrial fibrillation in Sweden and GermanyLinus Jönsson, Asa Eliasson, John Kindblom, et al.Applied Health Economics and Health Policy|January 29, 2011
Influence of patient co-payments on atypical antipsychotic choice in Poland: implications once generic atypicals are availableMagda Wladysiuk, Aleksander Araszkiewicz, Brian Godman, et al.Applied Health Economics and Health Policy|January 29, 2011
Current and future economic burden of osteoporosis in New ZealandPaul Brown, Rob McNeill, William Leung, et al.Applied Health Economics and Health Policy|December 23, 2010
Determinants of out-of-pocket health expenditure in China: analysis using China Health and Nutrition Survey dataXuedan You, Yasuki KobayashiApplied Health Economics and Health Policy|November 4, 2010
Reducing uncertainty in value-based pricing using evidence development agreements: the case of continuous intraduodenal infusion of levodopa/carbidopa (Duodopa®) in SwedenMichael Willis, Ulf Persson, York Zoellner, et al.Applied Health Economics and Health Policy|November 4, 2010
Cost effectiveness of establishing a neonatal screening programme for phenylketonuria in LibyaErikas Sladkevicius, Rodney J Pollitt, Ali Mgadmi, et al.Applied Health Economics and Health Policy|February 22, 2011
Germany's decision rule for setting ceiling prices of drugs: a comparative analysis with other decision rulesAfschin GandjourPageof 118